Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results
Objective. Systemic lupus erythematosus (SLE) is an autoimmune systemic disease and its pathogenesis has not yet been completely clarified. Patients with SLE show a deranged lipid metabolism, which can contribute to the immunopathogenesis of the disease and to the accelerated atherosclerosis. Resolv...
Saved in:
Main Authors: | Luca Navarini, Tiziana Bisogno, Domenico Paolo Emanuele Margiotta, Alessandra Piccoli, Silvia Angeletti, Alice Laudisio, Massimo Ciccozzi, Antonella Afeltra, Mauro Maccarrone |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/5264195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic Lupus Erythematosus
by: Chaim Putterman, et al.
Published: (2012-01-01) -
Lupus Enteritis as an Initial Presentation of Systemic Lupus Erythematosus
by: Sisira Sran, et al.
Published: (2014-01-01) -
Resolution of depression: Antidepressant actions of resolvins
by: Satoshi Deyama, et al.
Published: (2025-02-01) -
The Pathology of T Cells in Systemic Lupus Erythematosus
by: Anselm Mak, et al.
Published: (2014-01-01) -
Treatment of Bullous Systemic Lupus Erythematosus
by: Lihua Duan, et al.
Published: (2015-01-01)